TY  - RPRT
TI  - The glucagon and GLP-1 receptor dual agonist DD01 for metabolic dysfunction-associated steatotic liver disease and steatohepatitis (DD01-DN-02): 12-week results from a randomised, double-blind, multicentre, placebo-controlled, phase 2 trial.
AU  - Mazen Noureddin
AU  - Winston Dunn
AU  - Rashmee Patil
AU  - Dimple Desai
AU  - Rohit Puskoor
AU  - Jaehee Shin
AU  - Dennis To
AU  - Adam C Bell
AU  - Daniel R Lee
AU  - Yen-Huei Lin
AU  - Seulki Lee
PY  - 2026
DO  - 10.1016/s2468-1253(26)00130-5
UR  - https://pubmed.ncbi.nlm.nih.gov/42480572/
ID  - 42480572
ER  -